Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

The Role of Healthcare Worker-Mediated Contact Networks in the Transmission of Vancomycin-Resistant Enterococci.

Klein EY, Tseng KK, Hinson J, Goodman KE, Smith A, Toerper M, Amoah J, Tamma PD, Levin SR, Milstone AM.

Open Forum Infect Dis. 2020 Feb 15;7(3):ofaa056. doi: 10.1093/ofid/ofaa056. eCollection 2020 Mar.

2.

Risk factors for extended-spectrum beta-lactamase-producing Enterobacterales bloodstream infection among solid organ transplant recipients.

Anesi JA, Lautenbach E, Tamma PD, Thom KA, Blumberg EA, Alby K, Bilker WB, Werzen A, Tolomeo P, Omorogbe J, Pineles L, Han JH.

Clin Infect Dis. 2020 Feb 28. pii: ciaa190. doi: 10.1093/cid/ciaa190. [Epub ahead of print]

PMID:
32149327
3.

Corrigendum to: Oral Vancomycin May Be Associated With Earlier Symptom Resolution Than Metronidazole for Hospitalized Children With Nonsevere Clostridioides difficile Infections.

Yin J, Kociolek LK, Same RG, Hsu AJ, Amoah J, Tamma PD.

Open Forum Infect Dis. 2020 Feb 25;7(2):ofaa041. doi: 10.1093/ofid/ofaa041. eCollection 2020 Feb.

4.

Comparing Propensity Score Methods versus Traditional Regression Analysis for the Evaluation of Observational Data: A Case Study Evaluating the Treatment of Gram-Negative Bloodstream Infections.

Amoah J, Stuart EA, Cosgrove SE, Harris AD, Han JH, Lautenbach E, Tamma PD.

Clin Infect Dis. 2020 Feb 18. pii: ciaa169. doi: 10.1093/cid/ciaa169. [Epub ahead of print]

PMID:
32069360
5.

Reply to Wang and Lai, and to Woerther, et al.

Sharara SL, Cosgrove SE, Tamma PD.

Clin Infect Dis. 2020 Feb 5. pii: ciaa118. doi: 10.1093/cid/ciaa118. [Epub ahead of print] No abstract available.

PMID:
32020173
6.

Unlikely Bedfellows: The Partnering of Antibiotic Stewardship Programs and the Pharmaceutical Industry.

Tamma PD, Cosgrove SE.

Clin Infect Dis. 2020 Jan 23. pii: ciaa056. doi: 10.1093/cid/ciaa056. [Epub ahead of print] No abstract available.

PMID:
31970391
7.

Oral Vancomycin May Be Associated With Earlier Symptom Resolution Than Metronidazole for Hospitalized Children With Nonsevere Clostridiodes difficile Infections.

Yin J, Kociolek LK, Same RG, Hsu AJ, Amoah J, Tamma PD.

Open Forum Infect Dis. 2019 Nov 14;6(12):ofz492. doi: 10.1093/ofid/ofz492. eCollection 2019 Dec. Erratum in: Open Forum Infect Dis. 2020 Feb 25;7(2):ofaa041.

8.

Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Children.

Chiotos K, Hayes M, Gerber JS, Tamma PD.

J Pediatric Infect Dis Soc. 2020 Feb 28;9(1):56-66. doi: 10.1093/jpids/piz085.

PMID:
31872226
9.

Is Piperacillin-Tazobactam Effective for the Treatment of Pyelonephritis Caused by ESBL-producing Organisms?

Sharara SL, Amoah J, Pana ZD, Simner PJ, Cosgrove SE, Tamma PD.

Clin Infect Dis. 2019 Dec 20. pii: ciz1205. doi: 10.1093/cid/ciz1205. [Epub ahead of print]

PMID:
31859352
10.

The inconvincible patient: how clinicians perceive demand for antibiotics in the outpatient setting.

Kohut MR, Keller SC, Linder JA, Tamma PD, Cosgrove SE, Speck K, Ahn R, Dullabh P, Miller MA, Szymczak JE.

Fam Pract. 2020 Mar 25;37(2):276-282. doi: 10.1093/fampra/cmz066.

PMID:
31690948
11.

Research needs in antibiotic stewardship.

Morris AM, Calderwood MS, Fridkin SK, Livorsi DJ, McGregor JC, Mody L, Moehring RW, Pakyz AL, Stenehjem E, Szymczak JE, Tamma PD.

Infect Control Hosp Epidemiol. 2019 Dec;40(12):1334-1343. doi: 10.1017/ice.2019.276. Epub 2019 Oct 30. No abstract available.

PMID:
31662139
12.

Things We Do for No Reason: Lumbar Punctures in Low-Risk Febrile Infants with Bronchiolitis.

Berk J, Biondi E, Tamma PD, Herzke C.

J Hosp Med. 2019 Oct 23;14:E1-E3. doi: 10.12788/jhm.3317. [Epub ahead of print] No abstract available.

PMID:
31634097
13.

Impact of an Antibiotic Stewardship Program on the Incidence of Vancomycin-Associated Acute Kidney Injury in Hospitalized Children.

Hsu AJ, Tamma PD.

J Pediatr Pharmacol Ther. 2019 Sep-Oct;24(5):416-420. doi: 10.5863/1551-6776-24.5.416.

14.

Evaluation of the Direct MacConkey Method for Identification of Carbapenem-Resistant Gram-Negative Organisms from Rectal Swabs: Reevaluating Zone Diameter Cutoffs.

Workneh M, Wang R, Kazmi AQ, Chambers KK, Opene BNA, Lewis S, Goodman K, Tamma PD, Carroll KC, Milstone AM, Simner PJ.

J Clin Microbiol. 2019 Nov 22;57(12). pii: e01127-19. doi: 10.1128/JCM.01127-19. Print 2019 Dec.

PMID:
31597748
15.

Imported Cases of Extensively Drug-Resistant Salmonella.

Simner PJ, Bergman Y, Tamma PD.

Pediatr Infect Dis J. 2019 Dec;38(12):e340. doi: 10.1097/INF.0000000000002450. No abstract available.

PMID:
31469779
16.

Optimizing the Management of Uncomplicated Gram-Negative Bloodstream Infections in Children: Translating Evidence From Adults Into Pediatric Practice.

Same RG, Hsu AJ, Tamma PD.

J Pediatric Infect Dis Soc. 2019 Nov 6;8(5):485-488. doi: 10.1093/jpids/piz051. No abstract available.

PMID:
31436812
17.

Admission Laboratory Values Accurately Predict In-hospital Mortality: a Retrospective Cohort Study.

Blanco N, Leekha S, Magder L, Jackson SS, Tamma PD, Lemkin D, Harris AD.

J Gen Intern Med. 2020 Mar;35(3):719-723. doi: 10.1007/s11606-019-05282-2. Epub 2019 Aug 20.

PMID:
31432440
18.

Molecular Epidemiology of Ceftriaxone Non-Susceptible Enterobacterales Isolates in an Academic Medical Center in the United States.

Tamma PD, Sharara SL, Pana ZD, Amoah J, Fisher SL, Tekle T, Doi Y, Simner PJ.

Open Forum Infect Dis. 2019 Aug 11;6(8):ofz353. doi: 10.1093/ofid/ofz353.

19.

The Likelihood of Developing a Carbapenem-Resistant Enterobacteriaceae Infection during a Hospital Stay.

Tamma PD, Kazmi A, Bergman Y, Goodman KE, Ekunseitan E, Amoah J, Simner PJ.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00757-19. doi: 10.1128/AAC.00757-19. Print 2019 Aug.

20.

Antibiotic stewardship in the intensive care unit: Challenges and opportunities.

Chiotos K, Tamma PD, Gerber JS.

Infect Control Hosp Epidemiol. 2019 Jun;40(6):693-698. doi: 10.1017/ice.2019.74. Epub 2019 May 3.

PMID:
31046851
21.

Predicting probability of perirectal colonization with carbapenem-resistant Enterobacteriaceae (CRE) and other carbapenem-resistant organisms (CROs) at hospital unit admission.

Goodman KE, Simner PJ, Klein EY, Kazmi AQ, Gadala A, Toerper MF, Levin S, Tamma PD, Rock C, Cosgrove SE, Maragakis LL, Milstone AM; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2019 May;40(5):541-550. doi: 10.1017/ice.2019.42. Epub 2019 Mar 27.

PMID:
30915928
22.

Reporting Extended-Spectrum β-Lactamase Positivity May Reduce Carbapenem Overuse.

Tamma PD, Cosgrove SE, Avdic E, Carroll KC, Simner PJ.

Open Forum Infect Dis. 2019 Feb 19;6(3):ofz064. doi: 10.1093/ofid/ofz064. eCollection 2019 Mar. No abstract available.

23.

Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections: How Long Is Long Enough?

Fabre V, Amoah J, Cosgrove SE, Tamma PD.

Clin Infect Dis. 2019 Nov 13;69(11):2011-2014. doi: 10.1093/cid/ciz223.

PMID:
30882137
24.

A Novel Phenotypic Method To Screen for Plasmid-Mediated Colistin Resistance among Enterobacteriales.

Bell DT, Bergman Y, Kazmi AQ, Lewis S, Tamma PD, Simner PJ.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e00040-19. doi: 10.1128/JCM.00040-19. Print 2019 May.

25.

A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World.

Tamma PD, Doi Y, Bonomo RA, Johnson JK, Simner PJ; Antibacterial Resistance Leadership Group .

Clin Infect Dis. 2019 Sep 27;69(8):1446-1455. doi: 10.1093/cid/ciz173.

26.

A methodological comparison of risk scores versus decision trees for predicting drug-resistant infections: A case study using extended-spectrum beta-lactamase (ESBL) bacteremia.

Goodman KE, Lessler J, Harris AD, Milstone AM, Tamma PD.

Infect Control Hosp Epidemiol. 2019 Apr;40(4):400-407. doi: 10.1017/ice.2019.17. Epub 2019 Mar 4.

PMID:
30827286
27.

Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms.

Tamma PD, Hsu AJ.

J Pediatric Infect Dis Soc. 2019 Jul 1;8(3):251-260. doi: 10.1093/jpids/piz002. Review.

28.

Integrating bedside nurses into antibiotic stewardship: A practical approach.

Monsees EA, Tamma PD, Cosgrove SE, Miller MA, Fabre V.

Infect Control Hosp Epidemiol. 2019 May;40(5):579-584. doi: 10.1017/ice.2018.362. Epub 2019 Feb 21. Review.

PMID:
30786944
29.

Association of a blood culture utilization intervention on antibiotic use in a pediatric intensive care unit.

Sick-Samuels AC, Woods-Hill CZ, Fackler JC, Tamma PD, Klaus SA, Colantuoni EE, Milstone AM.

Infect Control Hosp Epidemiol. 2019 Apr;40(4):482-484. doi: 10.1017/ice.2019.10. Epub 2019 Feb 15.

30.

A Decision Tree Using Patient Characteristics to Predict Resistance to Commonly Used Broad-Spectrum Antibiotics in Children With Gram-Negative Bloodstream Infections.

Sick-Samuels AC, Goodman KE, Rapsinski G, Colantouni E, Milstone AM, Nowalk AJ, Tamma PD.

J Pediatric Infect Dis Soc. 2019 Jan 25. doi: 10.1093/jpids/piy137. [Epub ahead of print]

PMID:
30690525
31.

Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae Bacteremia.

Tamma PD, Conley AT, Cosgrove SE, Harris AD, Lautenbach E, Amoah J, Avdic E, Tolomeo P, Wise J, Subudhi S, Han JH; Antibacterial Resistance Leadership Group.

JAMA Intern Med. 2019 Mar 1;179(3):316-323. doi: 10.1001/jamainternmed.2018.6226. Erratum in: JAMA Intern Med. 2019 Nov 1;179(11):1607.

32.

The Role of Ertapenem for the Treatment of Complicated Intra-abdominal Infections With a Positive Culture for Enterococcus faecalis.

Fabre V, Nemati K, Avdic E, Cosgrove SE, Amoah J, Tamma PD.

Open Forum Infect Dis. 2018 Dec 15;6(1):ofy339. doi: 10.1093/ofid/ofy339. eCollection 2019 Jan.

33.

Rethinking How Antibiotics Are Prescribed: Incorporating the 4 Moments of Antibiotic Decision Making Into Clinical Practice.

Tamma PD, Miller MA, Cosgrove SE.

JAMA. 2019 Jan 15;321(2):139-140. doi: 10.1001/jama.2018.19509. No abstract available.

PMID:
30589917
34.

Impact of a Prescriber-driven Antibiotic Time-out on Antibiotic Use in Hospitalized Patients.

Thom KA, Tamma PD, Harris AD, Dzintars K, Morgan DJ, Li S, Pineles L, Srinivasan A, Avdic E, Cosgrove SE.

Clin Infect Dis. 2019 Apr 24;68(9):1581-1584. doi: 10.1093/cid/ciy852.

PMID:
30517592
35.

Campylobacter Infections in Children.

Same RG, Tamma PD.

Pediatr Rev. 2018 Nov;39(11):533-541. doi: 10.1542/pir.2017-0285. Review. No abstract available.

36.

Applying Rapid Whole-Genome Sequencing To Predict Phenotypic Antimicrobial Susceptibility Testing Results among Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates.

Tamma PD, Fan Y, Bergman Y, Pertea G, Kazmi AQ, Lewis S, Carroll KC, Schatz MC, Timp W, Simner PJ.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01923-18. doi: 10.1128/AAC.01923-18. Print 2019 Jan.

37.

The antibiotic arms race: current and emerging therapy for Klebsiella pneumoniae carbapenemase (KPC) - producing bacteria.

Plazak ME, Tamma PD, Heil EL.

Expert Opin Pharmacother. 2018 Dec;19(18):2019-2031. doi: 10.1080/14656566.2018.1538354. Epub 2018 Nov 5. Review.

PMID:
30346216
38.

Increased 30-Day Mortality Associated With Carbapenem-Resistant Enterobacteriaceae in Children.

Chiotos K, Tamma PD, Flett KB, Karandikar MV, Nemati K, Bilker WB, Zaoutis T, Han JH.

Open Forum Infect Dis. 2018 Sep 10;5(10):ofy222. doi: 10.1093/ofid/ofy222. eCollection 2018 Oct.

39.

Two-Site Evaluation of the Colistin Broth Disk Elution Test To Determine Colistin In Vitro Activity against Gram-Negative Bacilli.

Simner PJ, Bergman Y, Trejo M, Roberts AA, Marayan R, Tekle T, Campeau S, Kazmi AQ, Bell DT, Lewis S, Tamma PD, Humphries R, Hindler JA.

J Clin Microbiol. 2019 Jan 30;57(2). pii: e01163-18. doi: 10.1128/JCM.01163-18. Print 2019 Feb.

40.

How frequently are hospitalized patients colonized with carbapenem-resistant Enterobacteriaceae (CRE) already on contact precautions for other indications?

Goodman KE, Simner PJ, Klein EY, Kazmi AQ, Gadala A, Rock C, Tamma PD, Cosgrove SE, Maragakis LL, Milstone AM; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2018 Dec;39(12):1491-1493. doi: 10.1017/ice.2018.236. Epub 2018 Oct 1.

41.

Single Academic Center Experience of Unrestricted β-d-Glucan Implementation.

Fabre V, Markou T, DeMallie K, Mehta S, Shoham S, Tamma PD, Zhang S, Cosgrove SE.

Open Forum Infect Dis. 2018 Aug 9;5(9):ofy195. doi: 10.1093/ofid/ofy195. eCollection 2018 Sep.

42.

Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates.

Tamma PD, Simner PJ.

J Clin Microbiol. 2018 Oct 25;56(11). pii: e01140-18. doi: 10.1128/JCM.01140-18. Print 2018 Nov. Review.

43.

Increasing Clindamycin and Trimethoprim-Sulfamethoxazole Resistance in Pediatric Staphylococcus aureus Infections.

Khamash DF, Voskertchian A, Tamma PD, Akinboyo IC, Carroll KC, Milstone AM.

J Pediatric Infect Dis Soc. 2019 Sep 25;8(4):351-353. doi: 10.1093/jpids/piy062.

PMID:
30011009
44.

Can the Ceftriaxone Breakpoints Be Increased Without Compromising Patient Outcomes?

Tamma PD, Pierce VM, Cosgrove SE, Lautenbach E, Harris A, Rayapati D, Han JH.

Open Forum Infect Dis. 2018 Jun 8;5(6):ofy139. doi: 10.1093/ofid/ofy139. eCollection 2018 Jun.

45.

Using Patient Risk Factors to Identify Whether Carbapenem-Resistant Enterobacteriaceae Infections Are Caused by Carbapenemase-Producing Organisms.

Simner PJ, Goodman KE, Carroll KC, Harris AD, Han JH, Tamma PD.

Open Forum Infect Dis. 2018 May 17;5(5):ofy094. doi: 10.1093/ofid/ofy094. eCollection 2018 May.

46.

Ambulatory Antibiotic Stewardship through a Human Factors Engineering Approach: A Systematic Review.

Keller SC, Tamma PD, Cosgrove SE, Miller MA, Sateia H, Szymczak J, Gurses AP, Linder JA.

J Am Board Fam Med. 2018 May-Jun;31(3):417-430. doi: 10.3122/jabfm.2018.03.170225.

47.

Antibiotic pressure on the acquisition and loss of antibiotic resistance genes in Klebsiella pneumoniae.

Simner PJ, Antar AAR, Hao S, Gurtowski J, Tamma PD, Rock C, Opene BNA, Tekle T, Carroll KC, Schatz MC, Timp W.

J Antimicrob Chemother. 2018 Jul 1;73(7):1796-1803. doi: 10.1093/jac/dky121.

48.

Reply to Chou and Trautner.

Chotiprasitakul D, Han JH, Lautenbach E, Cosgrove SE, Harris AD, Tamma PD.

Clin Infect Dis. 2018 Jul 18;67(3):483. doi: 10.1093/cid/ciy118. No abstract available.

PMID:
29617738
49.

Essential Resources and Strategies for Antibiotic Stewardship Programs in the Acute Care Setting.

Doernberg SB, Abbo LM, Burdette SD, Fishman NO, Goodman EL, Kravitz GR, Leggett JE, Moehring RW, Newland JG, Robinson PA, Spivak ES, Tamma PD, Chambers HF.

Clin Infect Dis. 2018 Sep 28;67(8):1168-1174. doi: 10.1093/cid/ciy255.

PMID:
29590355
50.

Successful Treatment of Persistent Burkholderia cepacia Complex Bacteremia with Ceftazidime-Avibactam.

Tamma PD, Fan Y, Bergman Y, Sick-Samuels AC, Hsu AJ, Timp W, Simner PJ, Prokesch BC, Greenberg DE.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02213-17. doi: 10.1128/AAC.02213-17. Print 2018 Apr.

Supplemental Content

Loading ...
Support Center